{
"NDC": {
"NDCCode": "53163-114-16",
"PackageDescription": "473 mL in 1 BOTTLE (53163-114-16) ",
"NDC11Code": "53163-0114-16",
"ProductNDC": "53163-114",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Altilan",
"ProprietaryNameSuffix": "Cl",
"NonProprietaryName": "Dextromethorphan Hbr, Phenylephrine Hcl, Chlorpheniramine Maleate",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20150301",
"EndMarketingDate": null,
"MarketingCategoryName": "OTC MONOGRAPH FINAL",
"ApplicationNumber": "part341",
"LabelerName": "Alternative Pharmacal Corporation",
"SubstanceName": "CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE",
"StrengthNumber": "4; 15; 10",
"StrengthUnit": "mg/5mL; mg/5mL; mg/5mL",
"Pharm_Classes": "Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2023-12-29",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20231231",
"StartMarketingDatePackage": "20150301",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}